Clicky

BioMarin Pharmaceutical Inc.(BMRN) News

Date Title
Jul 28 Leerink Partners Maintains a Buy on BioMarin Pharmaceutical (BMRN), Retains a $105 PT
Jul 22 BioMarin to Host Second Quarter 2025 Financial Results Conference Call and Webcast on Monday, August 4, 2025, at 4:30pm ET
Jul 16 Looking for a Growth Stock? 3 Reasons Why BioMarin (BMRN) is a Solid Choice
Jul 16 Wall Street Analysts Think BioMarin (BMRN) Could Surge 70.77%: Read This Before Placing a Bet
Jul 15 Unpacking Q1 Earnings: BioMarin Pharmaceutical (NASDAQ:BMRN) In The Context Of Other Therapeutics Stocks
Jul 11 Morgan Stanley Sees Rebound Potential in BioMarin (BMRN), Highlights Underappreciated Voxzogo Upside
Jul 10 Will BioMarin (BMRN) Beat Estimates Again in Its Next Earnings Report?
Jul 10 BioMarin Pharmaceutical (BMRN) Finalizes the Acquisition of Inozyme Pharma
Jul 1 BioMarin Announces Completion of Acquisition of Inozyme
Jun 28 BioMarin’s ROCTAVIAN Shows Sustained Efficacy, Safety Over 5 Years for Severe Hemophilia A
Jun 27 Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
Jun 26 The Top 5 Analyst Questions From BioMarin Pharmaceutical’s Q1 Earnings Call
Jun 24 BioMarin Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2025 Congress
Jun 23 Barclays Initiates BioMarin Pharmaceutical Inc. (BMRN) with a Buy Rating
Jun 23 2 Reasons to Watch BMRN and 1 to Stay Cautious
Jun 20 Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders
Jun 20 Does The Market Have A Low Tolerance For BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Fundamentals?
Jun 19 1 of Wall Street’s Favorite Stock to Target This Week and 2 to Think Twice About
May 28 Is the Options Market Predicting a Spike in BioMarin Pharmaceutical Stock?
May 27 2 Value Stocks with Exciting Potential and 1 to Steer Clear Of